NOETIK

Noetik is an AI-native biotechnology company based in South San Francisco, CA, founded in 2022. The company focuses on developing precision cancer immunotherapies by utilizing advanced machine learning techniques on extensive multimodal human patient data. Noetik aims to enhance clinical success rates for cancer therapies by addressing the translation gap between drug discovery and therapeutic outcomes.

The company's core technologies include proprietary AI platforms such as OCTO, a foundation model of virtual cell biology, and Perturb-map, which simulates perturbations to identify therapeutic targets. These platforms leverage vast datasets, including clinical and preclinical information, to provide insights into cell interactions within tissues. Noetik emphasizes an interdisciplinary approach, processing large datasets through automated pipelines to tailor therapies to individual patient biology. The company collaborates with partners like Agenus to develop AI-enabled predictive biomarkers for cancer treatments.